Description
Product Name: KLOW Blend (Custom Research Stack)
Components:
-
GHK-Cu 50 mg(Copper Tripeptide-1)
-
KPV 10 mg (Lysine-Proline-Valine)
-
BPC-157 10 mg (Body Protection Compound-157)
-
TB-500 10 mg (Thymosin Beta-4)
-
Common Ratio: Often configured as 50mg GHK-Cu / 10mg KPV / 10mg BPC-157 / 10mg TB-500 (Total 80mg)
Product Overview The KLOW Blend represents an evolution of the popular “Glow” protocols (typically GHK-Cu, BPC, and TB) by incorporating KPV to specifically target immune modulation and inflammation. This “all-in-one” research stack allows for the simultaneous investigation of multiple regenerative systems: the gut-brain axis, the musculoskeletal system, and the dermal extracellular matrix.
Mechanism of Action The KLOW Blend operates through a multi-target approach, leveraging the unique mechanisms of its four constituents:
-
GHK-Cu (Remodeling): Functions as a feedback signal for tissue remodeling, stimulating collagen and elastin synthesis while reducing oxidative stress. It is the primary driver for dermal density and cosmetic research in this stack.
-
KPV (Anti-Inflammatory): A C-terminal fragment of -MSH. KPV is a potent anti-inflammatory that targets the PEPT1 transporter in intestinal and immune cells, reducing the expression of NF-B and inflammatory cytokines without the side effects of steroids.
-
BPC-157 (Repair): Upregulates growth factor receptors (like VEGFR2) to promote angiogenesis and accelerates the healing of soft tissues (tendons, ligaments) and the gastrointestinal lining.
-
TB-500 (Mobility): Regulates actin polymerization (cytoskeletal structure), facilitating cell migration to sites of injury to support tissue regeneration and flexibility.
Research Applications This blend is specifically formulated for broad-spectrum regenerative research, including:
-
Systemic Recovery: Investigating the “additive” effects of combining local tissue repair agents (BPC/TB) with systemic anti-inflammatories (KPV).
-
Dermatological Health: Studies focusing on the reversal of photodamage and skin aging (GHK-Cu) supported by reduced systemic inflammation (KPV).
-
Autoimmune Models: Exploring the role of KPV and BPC-157 in mitigating symptoms of inflammatory bowel disease (IBD) or other autoimmune conditions.
-
Post-Surgical Healing: Researching accelerated wound closure and reduced scar formation.
Storage and Handling
-
Storage: Store lyophilized powder at 2-8°C.
-
Stability: Stable for 2 years in lyophilized form.
-
Reconstitution Note: Due to the presence of GHK-Cu, the solution may appear blue. Once reconstituted, the blend should be stored at 4°C and used within 3–4 weeks to prevent degradation of the less stable components (TB-500).
Disclaimer: This material is sold for research and development purposes only. It is not intended for human ingestion, diagnostic, therapeutic, or clinical procedures. All research must be conducted by qualified professionals in a laboratory setting.




